Kansas City Research Institute
Industry / private company
Location:
Kansas City, MO,
United States (USA) (US)
ISNI: -
ROR: https://ror.org/02s8t4443
Show on Map:
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study (2017)
Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, et al.
Journal article